Lenz & Staehelin advised South-Korean SK Telecom on all Swiss law aspects of its strategic partnership agreement with US-based quantum computing company, IonQ. The deal SK Telecom has agreed to transfer all its shares in
Tags :Andreas Rötheli
Lenz & Staehelin advised Unilabs on its acquisition of kempf und pfaltz, a dermatopathology institute,advised by Bär & Karrer. The teams Lenz & Staehelin advised Unilabs on all legal and structuring aspects of
Neo Medical, a Swiss technology company specializing in spine surgery, has announced the successful completion of a strategic equity investment, including the conversion of existing shareholder loans. The financing round was led by Gyrus Capital,
Twelve Capital, advised by Homburger, and Securis Investment Partners (“Securis”), two independent asset management specialists in Insurance-Linked Securities (“ILS”), announced their intention to merge, with both sets of shareholders remaining fully invested in the combined
Lenz & Staehelin advised Vaudoise Assurances on all legal and tax aspects of the acquisition of 100% of the share capital of Prevanto. Walder Wyss advised the sellers on all legal aspects of the transaction. Active
Holcim (Suisse) SA, the Swiss entity of the Holcim Group, announced its acquisition of the group Cand-Landi, a large industrial group active in the production and distribution of building materials, the exploitation of gravel pits
Unilabs, a leading international provider of diagnostic services, has acquired ADUS Radiologie, a radiology company with three centres in Dielsdorf, Kloten, and Affoltern am Albis. This strategic move follows the successful integration of RIMED, acquired
Inflexion and Gyrus Capital have announced that they have entered into an agreement for Inflexion to acquire a majority stake in dss+, a renowned provider of operations management consulting services with a purpose of saving
Unilabs, a leading diagnostic services provider, has announced it entered into a definitive agreement to acquire Proxilis, a diagnostics laboratory based in Geneva. The transaction closed in December 2022. The operator of test centres and laboratories
The Swiss private equity operator Gyrus Capital has acquired the 40% of the Italian group Consulcesi, a renowned company focus in digital services dedicated to healthcare professionals and pharmaceutical companies. Gyrus Capital is a European investment
